VYVANSE 10 MG CAPSULE

lisdexamfetamine dimesylate
$12.3516per EA
High Outlier
DEA Schedule CII

Strength

10 mg/1

NDC

59417010110

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA021977

On Market Since

8/30/2014

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+0.0%

3M

+0.0%

6M

-0.0%

1Y

-0.2%

3Y

+4.8%

5Y

+15.4%

All

+77.7%